TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function.
TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function.
复制标题
DOI:
10.1038/s41598-017-13739-9
复制
发表时间:
2017-10-23
影响因子:
4.6
通讯作者:
Dullaart RPF
中科院分区:
文献类型:
--
作者:
Gruppen EG;Garcia E;Connelly MA;Jeyarajah EJ;Otvos JD;Bakker SJL;Dullaart RPF
Trimethylamine-N-Oxide (TMAO) is a microbiome-related metabolite that is cleared by the kidney and linked to renal function. We explored the relationship between TMAO and all-cause mortality, and determined whether this association was modified by renal function. A prospective study was performed among PREVEND participants to examine associations of plasma TMAO with all-cause mortality. After median follow-up of 8.3 years in 5,469 participants, 322 subjects died. TMAO was positively associated with age, body mass index, type 2 diabetes mellitus and inversely with estimated glomerular filtration rate (eGFRcreatcysC)(all P < 0.001). Subjects in the highest versus lowest TMAO quartile had a crude 1.86-fold higher mortality risk (Ptrend < 0.001). After adjustment for several risk factors, TMAO remained associated with all-cause mortality [HR:1.36 (95% CI, 0.97–1.91),Ptrend = 0.016]. This association was lost after further adjustment for urinary albumin excretion and eGFR [HR:1.15 (95% CI, 0.81–1.64),Ptrend = 0.22]. The association of TMAO with mortality was modified by eGFR in crude and age- and sex-adjusted analyses (interaction P = 0.002). When participants were stratified by renal function (eGFR < vs. ≥90 mL/min/1.73 m2), TMAO was associated with all-cause mortality only in subjects with eGFR <90 mL/min/1.73 m2 [adjusted HR:1.18 (95% CI, 1.02–1.36),P = 0.023]. In conclusion, TMAO is associated with all-cause mortality, particularly in subjects with eGFR <90 mL/min/1.73 m2.
登录
查看更多内容
DOI:
10.1056/nejmoa1114248
发表时间:
2012-07-05
期刊:
The New England journal of medicine
影响因子:
--
作者:
Inker LA;Schmid CH;Tighiouart H;Eckfeldt JH;Feldman HI;Greene T;Kusek JW;Manzi J;Van Lente F;Zhang YL;Coresh J;Levey AS;CKD-EPI Investigators
通讯作者:
CKD-EPI Investigators
影响因子:
4.5
作者:
Dullaart RP;Garcia E;Jeyarajah E;Gruppen EG;Connelly MA
通讯作者:
Connelly MA
DOI:
10.1161/circheartfailure.115.002314
发表时间:
2016-01
期刊:
Circulation. Heart failure
影响因子:
--
作者:
Organ CL;Otsuka H;Bhushan S;Wang Z;Bradley J;Trivedi R;Polhemus DJ;Tang WH;Wu Y;Hazen SL;Lefer DJ
通讯作者:
Lefer DJ
影响因子:
4.9
作者:
Biedermann, Luc;Bruelisauer, Karin;Schuppler, Markus
通讯作者:
Schuppler, Markus
DOI:
10.1016/j.jpba.2015.02.040
发表时间:
2015-05-10
影响因子:
3.4
作者:
Ocque, Andrew J.;Stubbs, Jason R.;Nolin, Thomas D.
通讯作者:
Nolin, Thomas D.